COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 613
[57] Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain
barrier breakdown in the aging human hippocampus. Neuron.
2015;85(2):296-302.
[58] Zlokovic BV. Neurovascular pathways to neurodegeneration
in Alzheimer's disease and other disorders. Nat Rev Neurosci.
2011;12(12):723-738.
[59] Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating
neuroimmune systems in the neurobiology of depression. Nat Rev
Neurosci. 2016;17(8):497-511.
[60] Hodes GE, Kana V, Menard C, Merad M, Russo SJ.
Neuroimmune mechanisms of depression. Nat Neurosci.
2015;18(10):1386-1393.
[61] Brown WR, Thore CR. Review: cerebral microvascular
pathology in ageing and neurodegeneration. Neuropathol Appl
Neurobiol. 2011;37(1):56-74.
[62] Bell RD, Zlokovic BV. Neurovascular mechanisms and
blood-brain barrier disorder in Alzheimer's disease. Acta
Neuropathol. 2009;118(1):103-113.
[63] Diamond B, Huerta PT, Tracey K, Volpe BT. It takes guts to grow
a brain: Increasing evidence of the important role of the intestinal
microflora in neuro- and immune-modulatory functions during
development and adulthood. Bioessays. 2011;33(8):588-591.
[64] Schoindre Y, Terrier B, Kahn JE, et al. [Neurologic
manifestations and antineuronal antibodies in lupus
erythematosus: a literature review]. Rev Med Interne.
2012;33(2):97-104.
[65] Verheggen ICM, Meijboom RWE, Leijten FSS, de Steenwinkel
D, van den Born BJH, Postma AA, Jansen JFA, van Osch MJP,
Feelders RA, de Leeuw FE, van Buchem MA, Mutsaerts HJMM,
Terwindt GM. Blood3brain barrier permeability in patients with
late-onset multiple sclerosis. J Neurol. 2023;270(1):299-307.
613
